Paul Katongole

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Escherichia Coli

Radiation Induced

Prostate Cancer

Top Venues

Future oncology (London, England)

Oncology and therapy

Infectious agents and cancer

Infectious diseases institute ,Makerere

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Infectious diseases institute ,Makerere Aug 15 2012

Uganda

Medical Doctor :: Research and Care/Treatment

Publications

Paul Katongole, Obondo J Sande, Steven J Reynolds, Moses Joloba, Henry Kajumbula, Samuel Kalungi, Kenneth Ssebambulidde, Cynthia Nakimuli, Maxine Atuheirwe, Jackson Orem, Nixon Niyonzima
Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men. Oncology and therapy 10 (1) (2022)
Paul Katongole, Obondo J Sande, Sheilla Nabweyambo, Moses Joloba, Henry Kajumbula, Samuel Kalungi, Steven J Reynolds, Kenneth Ssebambulidde, Maxine Atuheirwe, Jackson Orem, Nixon Niyonzima
IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda Cancer Institute. Future oncology (London, England) (2021)
Paul Katongole, Fatuma Nalubega, Najjuka Christine Florence, Benon Asiimwe, Irene Andia
Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda. BMC infectious diseases 20 (1) (2020)
Paul Katongole, Obondo J Sande, Moses Joloba, Steven J Reynolds, Nixon Niyonzima
The human microbiome and its link in prostate cancer risk and pathogenesis. Infectious agents and cancer 15 (2020)
Paul Katongole, Obondo James Sande, Mulumba Yusuf, Moses Joloba, Steven J Reynolds, Nixon Niyonzima
Clinical characteristics and primary management of patients diagnosed with prostate cancer between 2015 and 2019 at the Uganda Cancer Institute. PloS one 15 (10) (2020)